XJPX
3391
Market cap6.12bUSD
Oct 09, Last price
2,123.50JPY
1D
-0.40%
1Q
-5.91%
Jan 2017
-80.87%
IPO
-16.40%
Name
Tsuruha Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tsuruha Holdings Inc. is a Japan-based drugstore holding company operating a nationwide chain of retail pharmacies. The company's stores sell pharmaceuticals, cosmetics, daily necessities, and food products, with additional operations in Thailand.
Key people
Jun Tsuruha
President, Chief Executive Officer, Chairman of Subsidiaries, Representative Director · since 2024
Ryutaro Miyake
Executive Officer, Chief Director of Finance & Accounting · since 2024
Yasuyuki Arima
Executive Officer · since 2022
Tsuyoshi Hanzawa
Executive Officer · since 2022
Yasuyuki Haruta
Executive Officer · since 2023
Takaomi Kinone
Executive Officer · since 2024
Yoshihiro Kobashi
Executive Officer · since 2021
Naotaka Kokawaji
Executive Officer · since 2021
Makoto Murakami
Executive Officer, Chief Director of Administration · since 2020
Shoichi Murakami
Executive Officer, President of Subsidiary, Director · since 2019
Kazuhiko Nomura
Executive Officer · since 2022
Norihito Ojima
Executive Officer · since 2024
Takamune Shibasaki
Executive Officer, Deputy Chief Director of Main Finance and Accounting Unit · since 2025
Akio Shiraishi
Executive Officer · since 2021
Koji Takahashi
Executive Officer, Deputy Chief Director of Main Human Resources and General Affairs Unit · since 2025
Junichi Tanaka
Executive Officer · since 2025
Hideaki Kirisawa
Executive Officer, President of Subsidiary, Director · since 2025
Masahiro Ofune
Director · since 2021
Kazuto Toyama
Executive Officer, Director · since 2024
Masahiro Yahata
Executive Officer, President of Subsidiary, Director · since 2020
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑02 | 2025‑05 | 2025‑02 | 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||